Search clinical trials for: Open Kinetic Chain

Total 10630 results

EndoPhotonix, Inc.

Unknown

SOLAR & ATRILAZE Atrial Fibrillation Trial (SAAF-T)

Atrial Fibrillation
Novartis

Terminated

Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.

Proliferative Diabetic Retinopathy

Switzerland
Myrexis Inc.

Terminated

Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol

Alzheimer's Disease

United States, Canada
University Hospital, Angers

Completed

Comparison Of The Analgesia Obtained By Infiltration For The Joinings Of Episiotomies (Liropep) (LiRoPep)

Parturients | Childbirth

France
Alcon Research

Completed

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Alcon Research

Completed

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Completed

Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Completed

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)

Ocular Hypertension | Glaucoma, Open-Angle

United States
Alcon Research

Completed

A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Completed

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Completed

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

Ocular Hypertension | Open-Angle Glaucoma

United States
Alcon Research

Completed

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Ocular Hypertension | Open-Angle Glaucoma

United States
National Taiwan University Hospital

Completed

Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

Taiwan
Boehringer Ingelheim

Completed

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

HIV Infections

United States
Alcon Research

Completed

Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
HaEmek Medical Center, Israel

Unknown

The Effect of Training With Custom-Made Biomechanical Perturbation Platform on Kinetics, Kinematics and Electromyography in Knee Osteoarthritis Patients

Knee Osteoarthritis

Israel
MedImmune LLC

Completed

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

Respiratory Syncytial Virus Infections

Chile, Argentina
OPKO Health, Inc.

Completed

Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5

Macular Degeneration

United States
Glaukos Corporation

Completed

A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects

Open-Angle Glaucoma

Spain, Germany, Italy, Netherlands
University Hospital, Geneva
Pamukkale University; Hospices Civils de Lyon; Hospital Clinic of Barcelona; German... and other collaborators

Unknown

Preop Hemodialysis or Intraop Ultrafiltration for Patients With Severe Renal Dysfunction Undergoing Open Heart Surgery (SeRenaD-CPB)

Cardiovascular Disease | Non-Dialysis Dependent Severe Renal Dysfunction

Germany, France, Spain, Switzerland, Turkey
Abbott

Completed

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Obesity

United States
Radboud University Medical Center
Zorgverzekeraar CZ; Scientific Institute for Dutch Pharmacists, The Netherlands

Completed

Implementation of a Pharmacy-Intervention to Enhance Prescription and Use of Lipid-Lowering Drugs

Cardiovascular Diseases

Netherlands
Radboud University Medical Center
Zorgverzekeraar CZ; Scientific Institute for Dutch Pharmacists, The Netherlands

Completed

Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy

Hypertension
Siemens Molecular Imaging

Completed

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Brain Cancer

United States
Medical University of Graz

Completed

The Influence of Fatty-Acids on Systemic and Subcutaneous Cytokines (TNF4)

Obesity | Type 2 Diabetes Mellitus

Austria
Medical University of Vienna

Completed

Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes

Glaucoma, Open-Angle | Intraocular Pressure | Circadian Rhythm | Regional Blood Flow

Austria
Public Health Solutions
Centers for Disease Control and Prevention

Unknown

Novel Internet-Based Interventions to Reduce Sexual Risk Among Men Who Have Sex With Men (5Part)

HIV Infections

United States
University of Witwatersrand, South Africa

Completed

Comparison Of Trabeculectomy Versus The Ex-PRESS Miniature Glaucoma Device In The Same Patient: A Prospective Randomized Study (XVT-USF)

Glaucoma

South Africa
University Of Perugia

Completed

Bacillus of Calmette and Guerin (BCG) Versus Gemcitabine For Intravesical Therapy In High Risk Superficial Bladder Cancer

Bladder Cancer

Italy
Herbert Irving Comprehensive Cancer Center

Completed

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

Amyloidosis

United States
University of Utah
National Institute of Mental Health (NIMH)

Completed

Further Studies of Attention Deficit Disorder - Residual Type (RT)

Attention Deficit Hyperactivity Disorder

United States
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.

Tumors | Non-Hodgkins's Lymphoma

United States
University of California, San Francisco

Completed

Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus

Patent Ductus Arteriosus

United States
UMC Utrecht

Unknown

Dutch Randomised Endovascular Aneurysm Management (DREAM-) Trial

Abdominal Aortic Aneurysm
DiObex

Terminated

Open Label Safety & Pharmacodynamic Study 24Wk w/DIO-902 Combo w/Metformin & Atorvastatin in T2DM Patients

Type 2 Diabetes

Australia, United States, New Zealand
Hospital Infantil Cândido Fontoura

Completed

Evaluation of Topical Lidocaine Spray as Adjuvant to Upper Gastrointestinal Endoscopy in Children

Dyspepsia | Abdominal Pain | Gastroesophageal Reflux Disease | Malabsorption Syndrome

Brazil
Mt. Sinai Medical Center, Miami
Genentech, Inc.; Sanofi-Synthelabo

Completed

Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
Northwell Health
Eisai Inc.

Completed

Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation

Epilepsy | Developmental Disabilities | Mental Retardation

United States
Provident Clinical Research
Reliant Pharmaceuticals

Unknown

An Open-Label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Mixed Dyslipidemia
National University Hospital, Singapore

Unknown

External Micropulse Diode Laser Transscleral Trabeculoplasty (EMDLT) for Severe Open Angle Glaucoma (EMDLT)

Primary Open Angle Glaucoma

Singapore
Sino-Swed Pharmaceutical Corporation

Completed

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

Carcinoma Surgery | Parenteral Nutrition | Post-Operative Hospital Stay

China
Northwestern Ophthalmic Institute S.C.
Research to Prevent Blindness

Completed

Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs

Primary Open Angle Glaucoma | Ocular Hypertension

United States
Nventa Biopharmaceuticals Corporation

Unknown

Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

United States
Abbott

Completed

A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)

Psoriatic Arthritis
ARCA Biopharma, Inc.

Terminated

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

Acute Ischemic Stroke

United States, Canada
Federal University of São Paulo

Unknown

Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves and Second Trabeculectomy in Glaucoma Patients

Open Angle Glaucoma

Brazil
Scil Technology GmbH
FGK Clinical Research GmbH

Unknown

Pilot Study on MD05 in Comparison With Open Flap Debridement in Patients Undergoing Periodontal Surgery

Periodontal Bone Loss | Alveolar Bone Loss

Hungary
Alcon Research

Completed

A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension

Ocular Hypertension | Open-Angle Glaucoma

United States
POZEN

Completed

An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers

Healthy

United States
Pfizer

Terminated

A Multicenter, Open Label Trial To Evaluate Pain Relief With Intravenous Followed By Oral Therapy With Parecoxib/Valdecoxib 40 Mg/Day For Treatment Of Post-Laparoscopic Surgery Pain

Pain, Post Surgical

Argentina

3

Subscribe